BioSpace News Archive

Career Advice

How to Find Dream Job For Yourself

Here we outline how to figure out what your dream job is and how to find dream job among the hundreds of job listings out there. This guide will help organize your job search.

October 3, 2019
·
3 min read
·
Laura Brothers
Employer Resources

7 Branding Tips in the Life Sciences

Here are some branding tips on how you can enhance your brand. These tips can help you improve the sales figure of your company and keep your profit arrows towards the sky.

October 3, 2019
·
6 min read
·
Katie Roth, SHRM SCP, SPHR
Business

Health Benefits are a Hot Topic Among Life Sciences Professionals

According to the 2019 BioSpace Ideal Employer Report, health benefits are now one of the top three most important attributes life science professionals consider when looking for an employer.

October 3, 2019
·
4 min read
·
Porschia Parker
BioCapital

Pushing to Improve Immunotherapies, Arcellx Raises $85 Million in Series B

The company plans to use the funds raised to advance the ARC-T and sparX programs, including development of a bivalent BCMA-targeted therapy in multiple myeloma and a CD123-targeted treatment in acute myeloid leukemia.

October 3, 2019
·
2 min read
·
Mark Terry
BioMidwest

Researchers Create Advanced Tech to Grow and Test Cancer Cells

Researchers at the University of Michigan have developed an advanced petri dish called a 3D scaffold that can allow the same cell growth and testing, but without the use of the lab animals and in a much shorter period.

October 3, 2019
·
2 min read
·
Mark Terry
Drug Development

Novartis Eyes New Cosentyx Approval After Positive Axial Spondyloarthritis Trial

In a Phase III trial, Cosentyx showed a significant and clinically meaningful reduction in disease activity for patients versus placebo.

October 3, 2019
·
2 min read
·
Alex Keown
New Study Finds Wider Adoption of Biosimilars Could Save States and Taxpayers Billions

Biosimilars have been slow to gain traction in the U.S. market. Some of this is intentional on the part of the drug industry, which has found a number of different approaches to stalling biosimilar competition.

October 3, 2019
·
3 min read
·
Mark Terry
Bio NC

RFPI Receives Federal Grant To Develop Novel Evaluation Tool For Asymptomatic Patients At Risk For Peripheral Arterial Disease

RFPi Inc. has received a grant from the National Institutes of Health to develop a novel, imaging-based medical device that health-care providers could use to test asymptomatic patients at risk for peripheral arterial disease.

October 3, 2019
·
3 min read
Drug Development

New Data from Enanta’s Phase 2a Human Challenge Study of EDP-938 for RSV Demonstrates Highly Statistically Significant Reductions (p<0.001) in Total Symptom Score, Mucus Weight and RSV Viral Load as Measured by RT-PCR Assay and by Plaque Assay

Enanta Pharmaceuticals, Inc. announced that new data from its Phase 2a Human Challenge Study of EDP-938 is being presented as a late-breaker oral presentation today at IDWeek™ 2019 in Washington, D.C. EDP-938 is Enanta’s lead N-protein inhibitor being developed for the treatment of RSV infection.

October 3, 2019
·
6 min read
Genetown

Governor Raimondo and URI President Dooley Announce Second Round of Rhode Island Innovation Campus Projects

Governor Gina Raimondo joined with University of Rhode Island President David Dooley to announce the second round of RI Innovation Campus projects that will catalyze academic research into new commercial products and businesses.

October 3, 2019
·
7 min read